Does Dr. MARCELO ANTUNES have financial conflicts of interest?

Dr. MARCELO ANTUNES (MD) has received a total of $1,303 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,303 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MARCELO ANTUNES?

According to CMS Open Payments data, Dr. MARCELO ANTUNES received funding from GALDERMA LABORATORIES, L.P ($448), ABBVIE ($286), and REGENERON HEALTHCARE SOLUTIONS ($141).

Does Dr. MARCELO ANTUNES receive research grants or speaking fees?

Dr. MARCELO ANTUNES has received $1,303 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MARCELO ANTUNES

MDReal-Time Hydrated

Specialty: Otolaryngology, Plastic Surgery within the Head & Neck

Practice Location: AUSTIN, TX 78758

NPI Number: 1871791558

LIFETIME INDUSTRY VALUE

$1,303

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ANTUNES is a verified Otolaryngology, Plastic Surgery within the Head & Neck practitioner based in AUSTIN, TX.

Between 2021 and 2024, Dr. ANTUNES had an overall industry promotional and research financial footprint of $1,303 as recorded in the federal CMS Open Payments database.

$1,303 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ANTUNES's primary funding source is GALDERMA LABORATORIES, L.P, which accounts for $448 (representing 34.3% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GALDERMA LABORATORIES, L.P

Rank 1

$448

34.3%

ABBVIE

Rank 2

$286

22%

REGENERON HEALTHCARE SOLUTIONS

Rank 3

$141

10.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.